Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus

Cardiovascular Diabetology

Volumn 7, Issue , 2008, Pages

  Tentolouris, Nicholas ^a   Papazafiropoulou, Athanasia ^a   Moyssakis, Ioannis ^b   Liatis, Stavros ^a   Perrea, Despoina ^a   Kostakis, Maria ^a   Katsilambros, Nicholas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

ADULT; AGED; AGING; AORTA; AORTA DISEASE; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; DIET THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; ELASTICITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; PREDICTION; PREVALENCE; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; ULTRASOUND; UNIVARIATE ANALYSIS; CROSS-SECTIONAL STUDY; ECHOGRAPHY; HYPERGLYCEMIA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; STATISTICAL MODEL;

AGED; AGING; AORTA; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ELASTICITY; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 39049128416     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-7-1     Document Type: Article

References (35)

1. Stamler J Vaccaro O Neaton JD Wentworth D Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 1993, 16:434-444. 10.2337/ diacare.16.2.434 8432214
2. Kleinman JC Donahue RP Harris MI Finucane FF Madans JH Brock DB Mortality among diabetics in a national sample Am J Epidemiol 1988, 128:389-401. 3394705
3. Tentolouris N Liatis S Moyssakis I Tsapogas P Psallas M Diakoumopoulou E Voteas V Katsilambros N Aortic distensibility is reduced in subjects with type 2 diabetes and cardiac autonomic neuropathy Eur J Clin Invest 2003, 33:1075-1083. 10.1111/j.1365-2362.2003.01279.x 14636290
4. Stefanadis C Stratos C Boudoulas H Kourouklis C Toutouzas P Distensibility of the ascending aorta: Comparison of invasive and non-invasive techniques in healthy men and in men with arterial disease Eur Heart J 1990, 11:990-996. 2282929
5. Hopkins KD Lehmann ED Gosling RG Aortic compliance measurements: A non-invasive indicator of atherosclerosis? Lancet 1994, 343:1447. 10.1016/S0140-6736(94)92577-1 7911173
6. Reaven GM Banting lecture 1988: Role of insulin resistance in human disease Diabetes 1988, 37:1595-1607. 10.2337/diabetes.37.12.1595 3056758
7. Isomaa B Almgren P Tuomi T Forsén B Lahti K Nissén M Taskinen MR Groop L Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 2001, 24:683-689. 10.2337/ diacare.24.4.683 11315831
8. Lorenzo C Okoloise M Williams K Stern MP Haffner SM San Antonio Heart Study The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study Diabetes Care 2003, 26:3153-3159. 10.2337/ diacare.26.11.3153 14578254
9. McNeill AM Rosamond WD Girman CJ Heiss G Golden SH Duncan BB East HE Ballantyne C Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study) Am J Cardiol 2004, 94:1249-1254. 10.1016/j.amjcard.2004.07.107 15541239
10. Czernichow S Bertrais S Blacher J Oppert JM Galan P Ducimetière P Hercberg S Safar M Zureik M SU.VI.MAX. Vascular Study Metabolic syndrome in relation to structure and function of large arteries: A predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular Study Am J Hypertens 2005, 18:1154-1160. 10.1016/j.amjhyper.2005.04.006 16182103
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 1997, 20:1183-1197. 9203460
12. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Jones DW Materson BJ Oparil S Wright JT Jr Roccella EJ Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 2003, 42:1206-1252. 10.1161/01.HYP.0000107251.49515.c2 14656957
13. Friedewald WT Levy RI Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preperative ultracentrifuge Clin Chem 1972, 18:499-502. 4337382
14. Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 1999, 130:461-470. 10075613
15. Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985, 28:412-419. 10.1007/BF00280883 3899825
16. Boudoulas H Wooley CF Aortic Function Functional abnormalities of the aorta Armonk, New York: Futura publishing Co Toutouzas PK, Wooley CF 1996, 3-36.
17. Relimpio F Martinez-Brocca MA Leal-Cerro A Losada F Mangas MA Pumar A Astorga R Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic. Influences of age and gender Diabetes Res Clin Pract 2004, 65:135-142. 10.1016/ j.diabres.2003.12.003 15223225
18. Bruno G Merletti F Biggeri A Bargero G Ferrero S Runzo C Prina Cerai S Pagano G Cavallo-Perin P Casale Monferrato Study Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study Diabetes Care 2004, 27:2689-2694. 10.2337/ diacare.27.11.2689 15505006
19. Marchesini G Forlani G Cerrelli F Manini R Natale S Baraldi L Ermini G Savorani G Zocchi D Melchionda N WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes Diabet Med 2004, 21:383-387. 10.1111/j.1464-5491.2004.01115.x 15049944
20. Kompoti M Mariolis A Alevizos A Kyrazis I Protopsaltis I Dimou E Lentzas I Levisianou D Gova A Melidonis A Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes Cardiovasc Diabetol 2006, 5:21. 1618385 17020601 10.1186/1475-2840-5-21
21. Martens FM van der Graaf Y Dijk JM Olijhoek JK Visseren FL Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease Atherosclerosis 17374372
22. Maple-Brown L Cunningham J Celermajer DS O'Dea K Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome Clin Endocrinol (Oxf) 2007, 66:419-425. 10.1111/j.1365-2265.2007.02749.x 17302878
23. Kilpatrick ES Rigby AS Atkin SL Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial Diabetes Care 2007, 30:702-712.
24. Alexander CM Landsman PB Teutsch SM Haffner SM NCEP-defined metabolic syndrome, diabetes, and the prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes Care 2003, 52:1210-1214.
25. Hopkins KD Lehmann ED Jones RL Turay RC Gosling RG A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects Diabetes Care 1996, 19:501-503. 10.2337/ diacare.19.5.501 8732717
26. Sims TJ Rasmussen LM Oxlund H Bailey AJ The role of glycation cross-links in diabetic vascular stiffening Diabetologia 1996, 39:946-951. 10.1007/BF00403914 8858217
27. Chappey O Dosquet C Wautier MP Wautier JL Advanced glycation end products, oxidant stress and vascular lesions Eur J Clin Invest 1997, 27:97-108. 10.1046/j.1365-2362.1997.710624.x 9061302
28. Ahlgren AR Sundkvist G Wollmer P Sonesson B Lanne T Increased aortic stiffness in women with type 1 diabetes mellitus is associated with diabetes duration and autonomic nerve function Diabet Med 1999, 16:291-297. 10.1046/j.1464-5491.1999.00079.x 10220202
29. De Angelis L Millasseau SC Smith A Viberti G Jones RH Ritter JM Chowienczyk PJ Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes Hypertension 2004, 44:67-71. 10.1161/ 01.HYP.0000130482.81883.fd 15148292
30. Lehmann ED Hopkins KD Gosling RG Increased aortic stiffness in women with NIDDM Diabetologia 1996, 39:870-871. 10.1007/s001250050526 8817116
31. UKPDS 38 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 1998, 317:703-713. 28659 9732337
32. Tentolouris N Papazafiropoulou A Liatis S Moyssakis I Perrea D Soldatos RP Katsilambros N Components of the metabolic syndrome, but not the metabolic syndrome per se, are associated with aortic distensibility Nutr Metab Cardiovasc Dis
33. Laurent S Boutouyrie P Asmar R Gautier I Laloux B Guize L Ducimetiere P Benetos A Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients Hypertension 2001, 37:1236-1241. 11358934
34. De Angelis L Millasseau SC Smith A Viberti G Jones RH Ritter JM Chowienczyk PJ Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham Heart Study Hypertension 2004, 43:1239-1245. 10.1161/01.HYP.0000128420.01881.aa 15123572
35. Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabet Med 1998, 15:539-553. 10.1002/ (SICI)1096-9136(199807)15:7<539::AID-DIA668<3.0.CO;2-S 9686693